Call for paper 〔OPEN〕

My submissions

〔CLOSED〕
Registration 〔OPEN〕

My tickets

〔CLOSED〕
Introduction

Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR), and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 will build on the success of the previous conference, which was widely praised for the quality of its program and inspirational contributions.

The conference format is designed to bring together basic, translational, and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort. The program will comprise Keynote Lectures, Plenary Symposia, Scientific Symposia, Meet-the-Expert sessions, and Oral and Poster presentations with ample time for discussion.

It will provide up-to-date information on both targeted and immunological approaches to interfere with cancer, for which major progress has been made in recent years. Along with these encouraging developments, the program will focus on the challenges that lie ahead of us—to increase our fundamental understanding of tumor heterogeneity and drug resistance mechanisms, to better stratify patients for therapy, and to increase the numbers of patients with durable clinical responses. Furthermore, ample attention will be given to the role of the microbiome and other microenvironmental factors influencing therapy response. Finally, technical advances like single-cell sequencing and relevant in vivo/ex vivo models will be covered. The program will offer high value through Plenary and Poster sessions, providing an excellent forum to share new data and network with colleagues.

Call for paper

Important date

2017-02-06
Abstract submission deadline

Submission Topics

CELL AND TUMOUR BIOLOGY

  • Cell Proliferation/cell cycle

  • Cell Death / Autophagy

  • Oncogenes and Tumour Suppressor Genes

  • Tumour Progression: Invasion and Metastasis

  • Metastases and EMT

  • Tumour Microenvironment

  • Tumour Angiogenesis

  • Tumour Immunology AND Inflammation

  • Aging and Cancer

  • Senescence

  • Cancer Cell Metabolism

  • Cancer Initiating Cells / Cancer Stem Cells

  • Tumour heterogeneity

CANCER GENOMICS, EPIGENETICS and GENOMIC INSTABILITY

  • Genomic Alterations in Cancer

  • Functional  Genomics

  • Epigenetic mechanisms and RNA

  • Genetic instability

  • Deep sequencing

SIGNALING PATHWAYS

  • Receptors and Signal Transduction

  • Gene Expression, Transcriptional Regulation

  • Systems biology

  • Computational models of biological systems

  • Omics technologies

CARCINOGENESIS

  • Mutagenesis, Carcinogen Metabolism

  • Promotion and Progression

  • DNA Damage and Repair

  • Viral Oncogenesis

TRANSLATIONAL RESEARCH

  • Organ Site-Specific Investigations: Preclinical, Diagnosis, Treatment

  • Molecular pathology

  • Biomarkers with clinical relevance, imaging

  • Prognostic biomarkers of therapy response

  • Prognostic value of oncogenomics

  • Clinical Phase I/II trials with targeted drugs and novel agents

  • Bioinformatics in therapies and clinical trials

  • Animal models of cancer

  • Infrastructures (biobanks, databases, genomic resources, others)

EXPERIMENTAL / MOLECULAR THERAPEUTICS, PHARMACOGENOMICS

  • Drug Discovery / Drug Design

  • Novel Targets, Delivery Systems

  • Mechanisms of Drug Action, Drug Profiling

  • Drug Resistance

  • Novel Approaches to Diagnosis of Cancer

  • New Therapies

  • Companion diagnostics

  • Personalized medicine

TUMOUR IMMUNOLOGY

  • Tumour Immunology

  • Immune Suppression and Escape

  • Tumor antigens and immune effectors

  • Immunotherapy and Cancer Vaccines

  • Cancer vaccines: preclinical and clinical studies

RADIOBIOLOGY / RADIATION ONCOLOGY

  • Tumour Cell Sensitization to Radiotherapy

  • Radiation-activated Signaling Pathways

  • Cell Cycle and Apoptosis in Radiation  Responses

  • Radiation Oncology; Preclinical and Clinical

  • Translational radiation research

MOLECULAR AND GENETIC EPIDEMIOLOGY

  • Risk Factors

  • Biomarkers

  • Risk Assessment

  • Susceptibility Genes

  • Genotype / Phenotype Correlations

  • Genetic Polymorphisms and Cancer Susceptibility

  • Epidemiology 

PREVENTION and EARLY DETECTION

  • Preclinical Prevention Studies, Markers and Prevention

  • Clinical Prevention Studies

  • Vaccination Against Cancer

MOUSE MODELS

  • Transgenic models

  • Chemical carcinogenesis

  • PDXs

  • Humanised mouse models

OTHER

Submit Comment
Verify Code Change Another
All Comments
Important Date

  • Conference Date

    Jun 24

    2017

    to

    Jun 26

    2017

  • Feb 06 2017

    Abstract Submission Deadline

  • Jun 26 2017

    Registration deadline

Contact Information
Login to view full contact details